










 





CASI Ken Keyong Ren Insider Trades for CASI Pharmaceuticals Inc.


































Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































CASI Pharmaceuticals Inc.

                  NASDAQ: CASI
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

CASI Pharmaceuticals Inc.



Market closed
 --Quotes are delayed by 20 min
Jul 27, 2017, 3:56 p.m.


CASI

/quotes/zigman/35058022/composite


$
1.04




Change

-0.03
-2.80%

Volume
Volume 7,833
Quotes are delayed by 20 min








/quotes/zigman/35058022/composite
Previous close

$
			1.07
		


$
				1.04
			
Change

-0.03
-2.80%





Day low
Day high
$1.04
$1.08










52 week low
52 week high

            $0.91
        

            $1.76
        


















Insider Activity


Individual




Ken Keyong Ren



Dr. Ken K. Ren, MD PhD, is Chief Executive Officer & Director at CASI Pharmaceuticals, Inc. and General Manager at ImmunoVentis, Inc. He is on the Board of Directors at CASI Pharmaceuticals, Inc.
He received his doctorate degree from the State University of New York at Buffalo and a doctorate degree from Shandong Medical University.



Transactions


Date
Shares
Transaction
Value





01/19/2016
300


 
Acquisition at $0.71 per share.


213


01/19/2016
300


 
Acquisition at $0.71 per share.


213


01/19/2016
6,063


 
Acquisition at $0.72 per share.


4,365


01/19/2016
6,063


 
Acquisition at $0.72 per share.


4,365


01/19/2016
1,100


 
Acquisition at $0.74 per share.


814


01/19/2016
1,100


 
Acquisition at $0.74 per share.


814


01/19/2016
7,537


 
Acquisition at $0.73 per share.


5,502


01/19/2016
7,537


 
Acquisition at $0.73 per share.


5,502





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Wei-Wu  He 
Executive Chairman




Dr. Ken Keyong Ren 
Chief Executive Officer & Director




Ms. Cynthia Wong Hu 
COO, Secretary, Vice President & General Counsel




Ms. Sara B. Capitelli 
Chief Accounting Officer & Vice President-Finance




Dr. James E. Goldschmidt 
Vice President-Business Development




Dr. Quan  Zhou 
Director




Mr. Franklin Cary Salisbury 
Independent Director




Dr. Rajesh C.  Shrotriya 
Independent Director




Mr. Zuie Chin  Huang 
Independent Director




Dr. Yue Alexander Wu 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




9:28 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:24aDollar turns lower for the week following GDP report
9:18aGet ready for the less-profitable Amazon that you used to know 
9:18a‘Skinny’ repeal of Obamacare fails to pass in late-night Senate vote
9:17aGold turns higher as dollar holds loss after GDP report shows as-expected rebound
9:14aScaramucci provides a shocking Bannon comparison that defies anatomy
9:13aStock futures trim losses after GDP data; tech shares weigh on Nasdaq 
9:12aMattel stock price target cut to $22 from $24 at D.A. Davidson
9:11aStarbucks stock price target cut to $67 from $70 at Instinet
9:11aMasterCard stock price target raised to $153 from $134 at Instinet
9:11aCan Snap fall even more as lockups expire?
9:10aA high-powered Florida couple announces their ‘Trump Divorce’
9:10aVerizon stock price target raised to $47 from $46 at Instinet
9:10aAmazon’s free-spending ways hit earnings, but don’t expect a shift to thrift
9:09aKLA-Tencor stock price target raised to $100 from $95 at Instinet
9:09aU.S. GDP speeds up to 2.6% in 2nd quarter 
9:08aHot Pie from ‘Game of Thrones’ is selling direwolf bread in real life
9:08aEllie Mae's stock set for record selloff after results disappoints, outlook slashed
9:00aStock market set to extend fresh tech rout as Amazon disappoints; GDP data ahead
8:54aAtlantic Media selling ownership stake to organization run by Laurene Powell Jobs
8:50aRetail investors wait this long to dive into IPOs
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,796.55

+85.54
+0.39%





nasdaq

/quotes/zigman/12633936/realtime
6,382.19

-40.56
-0.63%





s&p 500

/quotes/zigman/3870025/realtime
2,475.42

-2.41
-0.10%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Kenna Rae Acker - Red Oak, TX | Intelius



























Sign In



We found Kenna Rae Acker in Red Oak, TX


Kenna Rae Acker

                                                                           Intelius found that Kenna Rae Acker  is  a male between 60 and 60 years old from Red Oak, TX.  We have connected them to
                12 addresses,
                9 phones,
                and 6 relatives or associates.
         





Also Known As

Kenna Rae Ren
Ken K Ren


Get Report Now

Age

Kenna Rae Acker is in his 60s

Kenna Has Lived In

Red Oak, TX
Malakoff, TX
Mabank, TX

Kenna's Relatives

Thomas Acker
George Acker
Orville Ren
Steve Ren







Kenna Rae Acker



Zodiac SignCapricorn



GenderMale



Professional Status
Executive at Accelovance Inc



Get Report Now










Want to know more about Kenna? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Kenna, or use our people search engine to find others.
Get Background Check on Kenna Rae Acker
Get a Criminal Check on Kenna Rae Acker
Get a Public Record Report on Kenna Rae Acker
Get a People Search Report on Kenna Rae Acker


Kenna Rae Acker's Contact Information
Known Cities Lived In
Find out where Kenna Rae Acker has lived as well as Kenna Rae Acker's phone numbers and email addresses.




Kenna Rae Acker Has Lived in 4 States
Texas Address for Kenna Rae Acker


305 L*** S****** D* 

Red Oak, TX


Has Lived In

Red Oak, TX
Malakoff, TX


Get Full Address Report










Phone Numbers Associated with Kenna Rae Acker

(240) ***-**** - Rockville, MD 
(240) ***-**** - Rockville, MD 
(240) ***-**** - Rockville, MD 


Get Full Phone Report



Email Addresses Associated with Kenna Rae Acker

k***n@***.com
k***n@***.com
r*n@***.com


Get Email Report




Kenna Rae Acker's Education Information
Known Schools Attended
Learn about Kenna Rae Acker's academic history.  Find out which schools Kenna Rae Acker attended, the dates attended as well as the degrees Kenna Rae Acker received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Kenna Rae Acker Has Attended 1 School
North High School 1971 – 1975                              


Kenna Rae Acker's Professional Information
Information regarding Kenna Rae Acker's professional history.  Find out previous places Kenna Rae Acker has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Kenna Rae Acker Has Worked at 4 Places
Company: Accelovance Inc
               Title: Executive
Company: Accelovance Inc
               Title: President China
Kenna Rae Acker's Experience
Title: Executive
               Company: Accelovance Inc
Job Details
               Company Size: $10 mil to less than $25 mil - Employee Range: 25 to less than 100
Title: President China
               Company: Accelovance Inc
Job Details
               Company Size: $10 mil to less than $25 mil - Employee Range: 25 to less than 100
Additional Professional Information on Kenna Rae Acker

 See Kenna Rae Acker's LinkedIn Profile



Kenna Rae Acker's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Kenna Rae Acker


Kenna Rae Acker's known Social Networks And Potential Email Matches

Find all of Kenna Rae Acker's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Kenna Acker
Username Matches

                  KennaAcker
                  AckerKenna
                  Kenna.Acker
                  Acker.Kenna
                  Kenna_Acker
                  Acker_Kenna
                  Kenna-Acker
                  Acker-Kenna
                  KAcker
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
K Acker







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













Ken Keyong  Ren - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Ken Keyong  Ren
Check out list of companies and businesses related to Ken Keyong  Ren. Find out Ken Keyong  Ren address and contact details. View other people related to Ken Keyong  Ren - coworkers, colleagues, companions, etc.
Address:   

CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE 20850 MD




Companies related to Ken Keyong  Ren
CIKCompany NamePositionCompany Address0000895051CASI Pharmaceuticals, Inc.Chief Executive Officer 9620 MEDICAL CENTER DR STE 300 ROCKVILLE 20850




Ken Keyong  Ren on the Web
Persons related to Ken Keyong  Ren - CASI Pharmaceuticals, Inc.NamePositionCityKenneth Walter  BairSVP, Research and Development ROCKVILLEThomas H  Bliss JrSVP, Bus. & Corp. Development ROCKVILLEMark R  BrayVice President, Research TORONTODONALD S  BROOKSDirector ROCKVILLEDONALD S  BROOKSDirector ROCKVILLEJames S  BurnsPresident and CEO ROCKVILLEJames S  BurnsPresident and CEO ROCKVILLEDWIGHT L  BUSHDirector ROCKVILLEDWIGHT L  BUSHDirector ROCKVILLEDWIGHT L  BUSHDirector ROCKVILLEDWIGHT L  BUSHDirector ROCKVILLEDWIGHT L  BUSHDirector ROCKVILLENEIL J  CAMPBELLPresident and COO ROCKVILLERONALD  CAPEDirector ROCKVILLERONALD  CAPEDirector ROCKVILLESARA B  CAPITELLIVP Fin & Principal Account Off ROCKVILLESARA B  CAPITELLIVP, Fin & Principal Accounting ROCKVILLESARA B  CAPITELLIVP, Finance & PAO ROCKVILLESARA B  CAPITELLIVP, Finance & PAO ROCKVILLESidor  CarolynROCKVILLECELGENE CORP /DE/10% Owner SUMMITMarc  CorradoV.P. Corporate Development ROCKVILLEMarc  CorradoVP Corporate Development ROCKVILLEHu  CynthiaROCKVILLEBush  DwightROCKVILLEWei-Wu  HeDirector ROCKVILLEWei-Wu  HeDirector ROCKVILLEWei-Wu  HeDirector ROCKVILLEWei-Wu  HeDirector ROCKVILLEWei-Wu  HeDirector ROCKVILLEHE XIE AI QI INVESTMENT MANAGEMENT (BEIJING) CO., LTD.BEIJINGChi Sing  HoCENTRALCynthia W.  HuCOO, General Counsel and Secy ROCKVILLECynthia W.  HuCOO, General Counsel & Sec ROCKVILLE,Cynthia W.  HuSee Remarks ROCKVILLECynthia W.  HuSee Remarks ROCKVILLEJames  HuangDirector ROCKVILLEJames  HuangDirector ROCKVILLEJames  HuangDirector ROCKVILLEJames  HuangDirector ROCKVILLECEVERA JENNIE  HUNTERDirector ROCKVILLECEVERA JENNIE  HUNTERDirector ROCKVILLECEVERA JENNIE  HUNTERDirector ROCKVILLECEVERA JENNIE  HUNTERDirector ROCKVILLECEVERA JENNIE  HUNTERDirector ROCKVILLEIDG-Accel China Growth Fund GP III Associates Ltd.K3IDG-Accel China Growth Fund III Associates L.P.K3IDG-Accel China Growth Fund III L.P.10% Owner K3IDG-Accel China III Investors L.P.K3Hunter-Cevera  JennieROCKVILLEUDO  KLEINSenior Vice President of R&D ROCKVILLEPETER S  KNIGHTDirector ROCKVILLEPETER S  KNIGHTDirector ROCKVILLEJianguang  LiBEIJINGDongliang  LinBEIJINGTak W.  MakDirector ROCKVILLETak W.  MakDirector ROCKVILLETak W.  MakDirector ROCKVILLETak W.  MakDirector ROCKVILLEBray  MarkROCKVILLERandall  MarkROCKVILLEMARK C M  RANDALLDirector ROCKVILLEMARK C M  RANDALLDirector ROCKVILLEMARK C M  RANDALLDirector ROCKVILLEKen  RenCEO and Director WEST DES MOINESKen Keyong  RenChief Executive Officer ROCKVILLEKen Keyong  RenChief Executive Officer ROCKVILLEKen Keyong  RenChief Executive Officer ROCKVILLEDANE R  SAGLIOChief Financial Officer ROCKVILLEDANE R  SAGLIOChief Financial Officer ROCKVILLEFranklin Cary  Salisbury jrDirector ROCKVILLECapitelli  SaraROCKVILLEHugo  ShongBEIJINGRAJESH C MD  SHROTRIYADirector IRVINERAJESH C MD  SHROTRIYADirector ROCKVILLECarolyn F  SidorCorp. VP and Chief Med. Ofcr ROCKVILLECarolyn F  SidorV.P. and Chief Medical Officer ROCKVILLESNOW MOON LTDROAD TOWNSPARKLE BYTE LTD10% Owner ROAD TOWNSpectrum Pharmaceuticals Cayman, L.P.HENDERSONSPECTRUM PHARMACEUTICALS INC10% Owner HENDERSONSPECTRUM PHARMACEUTICALS INCHENDERSONMak  TakROCKVILLEMICHAEL M  TARNOWDirector ROCKVILLEMICHAEL M  TARNOWDirector ROCKVILLEJINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP)  TIANJINTIANJINKathy  Wehmeir-DavisPrincipal Accounting Officer ROCKVILLEHe  Wei-WuROCKVILLECynthia  WongCOO, Gen Counsel and Secretary ROCKVILLECynthia  WongCOO & General Counsel ROCKVILLEAlex  WuDirector ROCKVILLEAlex  WuDirector ROCKVILLEAlex  WuDirector ROCKVILLEFei  YangGUANGZHOUSuyang  ZhangSHANGHAIQuan  ZhouDirector CENTRALAlexander A  ZukiwskiChief Medical Officer FLEMINGTON












 








Ken Keyong Ren M.D., Ph.D.: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 9:28 AM ET
Biotechnology

Company Overview of CASI Pharmaceuticals, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Ken Keyong Ren M.D., Ph.D.Chief Executive Officer and Director, CASI Pharmaceuticals, Inc.AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.See Board Relationships58$920,888As of Fiscal Year 2016
Background

		Dr. Ken Keyong Ren, M.D., Ph.D. has been Chief Executive Officer of CASI Pharmaceuticals, Inc. since April 4, 2013. Dr. Ren served as President of China Region at Accelovance, Inc. Dr. Ren served as Interim Chief Executive Officer of CASI Pharmaceuticals, Inc. from April 2, 2012 to April 4, 2013. He served as Chief Executive Officer of EntreMed Inc. He was the founder and key management team member of several U.S. based start-up companies with pharmaceutical development ... or service businesses in both China and the U.S. during the past 10 years. Prior to Accelovance, Dr. Ren was the Founder of AHT, Inc. of New Jersey, USA, which merged two years later with Novemed, a portfolio investment of a blue-chip public company in Hong Kong. Dr. Ren was a co-founder of China Innovation Center for Life Science (U.S.A) Corp., a New York based consulting firm in partnership with the Chinese Ministry of Science and Technology. It provided consulting services to healthcare and pharmaceutical industries in both China and the US during 1996-1999. Its clients included such multinationals as J&J, Novartis, BMS, Pfizer and Covance. He has been  a Director of CASI Pharmaceuticals, Inc. since December 2014. Dr. Ren served as a Fellow at the Rockefeller University during 1990-1993 and a Scientist in American Home Product during 1993 to 1995. He received a medical degree in China and a Ph.D. in SUNY at Buffalo, USA.Read Full Background




Corporate Headquarters
9620 Medical Center DriveRockville, Maryland 20850United StatesPhone: 240-864-2600Fax: 301-315-2437
Board Members Memberships
2014-PresentChief Executive Officer and DirectorCASI Pharmaceuticals, Inc.
Education
PhD 1990State University of New YorkMD 1986China
Other Affiliations
State University of New YorkChinaAccelovance, Inc.


Annual Compensation
Salary$300,000Total Annual Compensation$300,000
Stocks Options
All Other Compensation$7,950Exercisable Options$2,267,941Exercisable Options Value$108,484Unexercisable Options$157,817Unexercisable Options Value$18,985Total Value of Options$127,468Total Number of Options$2,425,758
Total Compensation
Total Annual Cash Compensation$307,950Total Short Term Compensation$300,000Other Long Term Compensation$7,950Total Calculated Compensation$920,888




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationLeonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President and Executive DirectorRegeneron Pharmaceuticals, Inc.$1.2MCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact CASI Pharmaceuticals, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft













Ken Keyong Ren | ICIJ Offshore Leaks Database































    ICIJ · The International Consortium of Investigative Journalists
    
Projects
About ICIJ
Donate












Offshore Leaks Database
Tax haven secrecy revealed


The Panama Papers
Offshore Leaks
About this data
Download


















The Panama Papers
Offshore Leaks
About this data
Download


Sign up for updates
Donate
About ICIJ
Previous investigations
icij.org
publicintegrity.org



Support us



Offshore Leaks Database Reading List

The Panama Papers
Offshore Leaks
About this data
Download














Search by country
People, companies and addresses connected to offshore entities


Search by jurisdiction
Offshore companies and trusts






To search, enter a term in the box. Leave it blank and select a country or jurisdiction to see a full list of names.










Officer
Ken Keyong Ren


Use the following code to embed this page and its visualization in your website. Width and height will adapt automatically.

      





Connected to 1 entity


 Linked countries: Not identified
 Data from: Offshore Leaks
The Offshore Leaks data is current through 2010
Search in 
 Got a tip? Help ICIJ investigate: contact us or leak to us securely


































Database powered by Neo4j. What is it?




        Connections
        


What do these terms mean?


Entity




Role
From 
To 
Incorporation
Jurisdiction
Status
Data From


CHINA BIOTECHNOLOGY, INC.
Director
2002-12-18
-
05-DEC-2002
British Virgin Islands
Struck / Defunct / Deregistered
Offshore Leaks


CHINA BIOTECHNOLOGY, INC.
Shareholder
2002-12-18
-
05-DEC-2002
British Virgin Islands
Struck / Defunct / Deregistered
Offshore Leaks













About this database
This ICIJ database contains information on almost 500,000 offshore entities that are part of the Panama Papers, the Offshore Leaks and the Bahamas Leaks investigations. The data covers nearly 40 years up to early 2016 and links to people and companies in more than 200 countries and territories.

About this data
Data sources
How to use this database
About ICIJ
Credits



Disclaimer
There are legitimate uses for offshore companies and trusts. We do not intend to suggest or imply that any persons, companies or other entities included in the ICIJ Offshore Leaks Database have broken the law or otherwise acted improperly. Many people and entities have the same or similar names. We suggest you confirm the identities of any individuals or entities located in the database based on addresses or other identifiable information. If you find an error in the database please get in touch with us.


Download data
The ICIJ Offshore Leaks Database is licensed under the Open Database License and contents under Creative Commons Attribution-ShareAlike license. Always cite the International Consortium of Investigative Journalists when using this data. You can download a raw copy of the database here.


Support us
Help ICIJ investigate






Please read the statement below before searching
There are legitimate uses for offshore companies and trusts. We do not intend to suggest or imply that any persons, companies or other entities included in the ICIJ Offshore Leaks Database have broken the law or otherwise acted improperly. Many people and entities have the same or similar names. We suggest you confirm the identities of any individuals or entities located in the database based on addresses or other identifiable information. If you find an error in the database please get in touch with us.






        I have read and understood the terms
      

Please accept the terms to continue



Please help us continue our work
ICIJ is an independent nonprofit news organization that brings journalists together to collaborate on critical in-depth global investigations

    We depend on the generous support of readers like you to help us expose corruption and hold the powerful to account
  

Donate now



Help spread the word
Share this story with your network

 Tweet
 Facebook
 Linkedin
 Email





Find this content interesting and worth supporting?
Donate to ICIJ. Help us continue investigating important global issues. Gifts made today will be matched up to $10,000.

Donate now


Donate now








Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft



















Ken Keyong Ren - CASI Pharmaceuticals Insider Transactions | TipRanks   





Go ProLogin / Sign Up Follow✓Get Real Time TransactionsInsider DetailsKen Keyong RenCASI Pharmaceuticals (CASI)CEO and Director, Director Not RankedKen Keyong Ren's PerformanceKen Keyong Ren has not reported any informative transactions and therefore cannot be ranked.How are Insiders Ranked? Insider Holdings 100.0% CASI Pharmaceuticals (CASI)$23KSee the Top Stocks by Insiders > Insider RolesCASI Pharmaceuticals (CASI): CEO and Director, DirectorSee the Top 25 Corporate Insiders > Most Profitable Insider TradeStock: CASI Pharmaceuticals (CASI)Transaction Type: Informative BuyDates: Jan 21, 2016 - Jan 21, 2017Gain: +0.0%See the Latest Stocks Traded by Insiders > Ken Keyong Ren's Trading Historybased on Form 4 Follow✓Get Real Time TransactionsCompany NameInsider PositionHolding ValueLast TransactionLast Transaction  AmountLast Transaction DateCASICASI PharmaceuticalsCEO and Director, Director$22,963Informative Buy$10,894.37Jan 21, 2016Ken Keyong Ren has not reported any informative transactions for CASI, therefore, performance cannot be measured. Track Record DateTransactionAmountNo. of SharesPrice per ShareProfitForm 4 Jan 21, 2016 Informative Buy $11K 15,000 $0.828 N/A See All Insider Trading from Today >You May Also LikeMeet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.Related LinksHow can I benefit from Insider Trading? >See the Top 25 Corporate Insiders >Go to Hot Stocks by Insiders >Find which stocks Insiders traded today >Become a TipRanks MemberGet the best Investing Tips & Hacks straight to your emailFree MembershipSubmitInsider Trading Daily NewsletterProfessional day-trading strategy based on predictive insider transactionsAnnual Return: +85.42%Learn More >Powered by
























